1. Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis.Lancet. 2021;398(10308):1359-1376. doi:10.1016/S0140-6736(21)01374-X
2. Walter KL. What is cirrhosis? JAMA. 2023;330(4):386. doi:10.1001/jama.2023.8935
3. Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World JGastroenterol. 2014;20(23):7312-7324. doi:10.3748/wjg.v20.i23.7312
4. Butterworth RF. Hepatic encephalopathy in cirrhosis: pathology andpathophysiology. Drugs. 2019;79(Suppl 1):17-21. https://doi.org/10.1007/s40265-018-1017-0
5. Frenette CT, Levy C, Saab S. Hepatic encephalopathy-relatedhospitalizations in cirrhosis: transition of care and closing the revolvingdoor. Dig Dis Sci. 2022;67(6):1994-2004. doi:10.1007/s10620-021-07075-2
6. Bajaj JS, Gentili A, Wade JB, Godschalk M. Specific challenges ingeriatric cirrhosis and hepatic encephalopathy. Clin GastroenterolHepatol. 2022;20(8):S20-S29. https://doi.org/10.1016/j.cgh.2022.04.035.
7. Mandiga P, Foris LA, Bollu PC. Hepatic encephalopathy. In: StatPearls.Treasure Island (FL): StatPearls Publishing: 2023.
8. R. Bacon B. Chapter 44. Cirrhosis and its complications. In: Kasper D,Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, eds. Harrison’sGastroenterology and Hepatology. 3rd ed. McGraw-Hill Education:2017:469.
9. Lu K. Cellular pathogenesis of hepatic encephalopathy: an update.Biomolecules. 2023;13(2):396. doi:10.3390/biom13020396
10. Nardelli S, Gioia S, Faccioli J, Riggio O, Ridola L. Hepatic encephalopathy- recent advances in treatment and diagnosis. Expert Rev GastroenterolHepatol. 2023;17(3):225-235. doi: 10.1080/17474124.2023.2183386.
11. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronicliver disease: 2014 practice guideline by the American Association forthe study of liver diseases and the European Association for the study ofthe liver. Hepatology. 2014;60(2):715-735. doi: 10.1002/hep.27210.
12. Hızarcıoğlu Gülşen H, Özen H. Hepatik ensefalopati. In: AltunbaşakŞ, editör. Çocuklarda Ensefalopati. 1. Baskı. Türkiye Klinikleri: 2021:p.86-94.
13. Thabut D, Bouzbib C, Meunier L, et al. Diagnosis and managementof hepatic encephalopathy: the French recommendations. Liver Int.2023;43(4):750-762. doi: 10.1111/liv.15510.
14. Thanapirom K, Wongwandee M, Suksawatamnuay S, et al.Psychometric hepatic encephalopathy score for the diagnosis ofminimal hepatic encephalopathy in Thai cirrhotic patients. J Clin Med.2023;12(2):519. doi: 10.3390/jcm12020519
15. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H.Neuropsychological characterization of hepatic encephalopathy. JHepatol. 2001;34(5):768-773. doi: 10.1016/s0168-8278(01)00026-5.
16. Amodio P, Campagna F, Olianas S, et al. Detection of minimalhepatic encephalopathy: normalization and optimization of thepsychometric hepatic encephalopathy score. A neuropsychologicaland quantified EEG study. J Hepatol. 2008;49(3):346-353. doi: 10.1016/j.jhep.2008.04.022.
17. Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, et al.Comparison of the most favoured methods for the diagnosis ofhepatic encephalopathy in liver transplantation candidates. Gut.2013;62(10):1497-1504. doi: 10.1136/gutjnl-2012-303262.
18. Kircheis G, Hilger N, Häussinger D. Value of critical flicker frequencyand psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy. Gastroenterol. 2014;146(4):961-969.doi: 10.1053/j.gastro.2013.12.026.
19. Kircheis G, Nilius R, Held C, et al. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepaticencephalopathy: results of a placebo-controlled, double-blind study.Hepatol. 1997;25(6):1351-1360. doi: 10.1002/hep.510250609.
20. Romero-Gómez M, Córdoba J, Jover R, et al. Value of the critical flickerfrequency in patients with minimal hepatic encephalopathy. Hepatol.2007;45(4):879-885. doi: 10.1002/hep.21586.
21. Karakaş S, Erdoğan E, Sak L, et al. Stroop test TBAG form:standardisation for Turkish culture, reliability and validity. J Clin Psy.1999;2(2):75-88.
22. Agarwal A, Taneja S, Chopra M, Duseja A, Dhiman RK. Animalnaming test - a simple and accurate test for diagnosis of minimalhepatic encephalopathy and prediction of overt hepatic encephalopathy.Clin Exp Hepatol. 2020;6(2):116-124. doi: 10.5114/ceh.2019.95105.
23. Erbay MF. Hepatik ensefalopati. Trd Sem. 2023;11(1):1-6. doi: 10.4274/trs.2023.223686.
24. Bellafante D, Gioia S, Faccioli J, Riggio O, Ridola L, Nardelli S. Old and newprecipitants in hepatic encephalopathy: a new look at a field in continuousevolution. J Clin Med. 2023;12(3):1187. doi: 10.3390/jcm12031187.
25. Ohnishi K, Sato S, Saito M, et al. Clinical and portal hemodynamicfeatures in cirrhotic patients having a large spontaneous splenorenaland/or gastrorenal shunt. Am J Gastroenterol. 1986;81(6):450-455.
26. Nardelli S, Riggio O, Gioia S, Puzzono M, Pelle G, Ridola L.Spontaneous porto-systemic shunts in liver cirrhosis: clinical andtherapeutical aspects. World J Gastroenterol. 2020;26(15):1726-1732.doi: 10.3748/wjg. v26.i15.1726
27. Amesur NB, Novelli P. Transjugular intrahepatic portosystemic shunt.In: StatPearls. Treasure Island (FL): StatPearls Publishing: 2023.
28. Dazıroğlu MEÇ, Yıldıran H. Intestinal dysbiosis and probiotic use:its place in hepatic encephalopathy in cirrhosis. Ann Gastroenterol.2023;36(2):141-148. doi: 10.20524/aog.2023.0776.
29. Kanbakan A. Acilci gözüyle hepatik ensefalopati. Updated January 3, 2019.Available from: https://acilci.net/acilci-gozuyle-hepatik-ensefalopati/.
30. Yu X, Jin Y, Zhou W, et al. Rifaximin modulates the gut microbiotato prevent hepatic encephalopathy in liver cirrhosis withoutimpacting the resistome. Front Cell Infect Microbiol. 2022;11:1427.doi: 10.3389/fcimb.2021.761192